🇺🇸 Ademetionine 1 in United States

5 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 21 April 2025 – 21 April 2026
• Total reports: 5

Most-reported reactions

1. Bacteraemia — 1 report (20%)
2. Death — 1 report (20%)
3. Haemolysis — 1 report (20%)
4. Pneumonia — 1 report (20%)
5. Portal Vein Thrombosis — 1 report (20%)

Source database →

Frequently asked questions

Is Ademetionine 1 approved in United States?

Ademetionine 1 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Ademetionine 1 in United States?

Zhejiang Hisun Pharmaceutical Co. Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.